Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumabKhalid Jazieh, Anant Madabhushi, Mohammadhadi Khorrami et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 57
A tumor vasculature–based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitorsMehdi Alilou, Anant Madabhushi, Vidya Sankar Viswanathan et al.|Science Advances|2022Cited by 41
Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung CancerPrantesh Jain, Anant Madabhushi, Mohammadhadi Khorrami et al.|Frontiers in Oncology|2021Cited by 29
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLCLukas Delasos, Anant Madabhushi, Mohammadhadi Khorrami et al.|npj Precision Oncology|2024Cited by 12
Rank acquisition impact on radiomics estimation (AсquIRE) in chest CT imaging: A retrospective multi-site, multi-use-case studyDmitry Cherezov, Anant Madabhushi, Vidya Sankar Viswanathan et al.|Computer Methods and Programs in Biomedicine|2023Cited by 8